CHEMICAL SCREENING AND OPTIMIZATION FACILITY - STRUCTURE ACTIVITY RELATIONSHIPS

化学筛选和优化设施 - 结构活性关系

• 批准号: 10022551
• 负责人: LEYI GONG
• 金额: $ 116.79万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-20 至 2024-09-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10022551
• 关键词: Agonist; Biochemical; Biological Assay; Chemicals; Computer Simulation; Contraceptive Agents; Contraceptive methods; Contractor; Contracts; Development; Discipline; Female Contraceptive Agents; Fertility; Freedom; Generations; Goals; In Vitro; Lead; Male Contraceptive Agents; Methods; Mission; National Institute of Child Health and Human Development; Outcome; Pharmaceutical Chemistry; Pharmacology; Pregnancy; Process; Production; Proteins; Recombinant Proteins; Regulation; Research; Role; Series; Services; Structure-Activity Relationship; United States; Woman; X-Ray Crystallography; assay development; computational chemistry; drug development; drug discovery; high throughput screening; in vivo evaluation; men; novel; reproductive; screening; small molecule

Nearly half of all pregnancies in the United States are unintended. There is a critical need for fertility regulation methods that fit the needs of women and men throughout their reproductive lives. The objective of this contract is to support the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in its mission to develop novel contraceptive methods by providing a Chemical Screening and Optimization Facility (CSOF) to identify safe and effective contraceptive agents for development. The CSOF also has an important role in the production of optimized compounds for early stage in vitro and in vivo testing.

在美国，近一半的怀孕是意外怀孕。迫切需要满足女性和男性整个生殖生涯需求的生育调节方法。该合同的目的是支持尤尼斯·肯尼迪·施赖弗国家儿童健康和人类发展研究所 (NICHD) 履行其开发新型避孕方法的使命，通过提供化学筛选和优化设施 (CSOF) 来识别安全有效的避孕药物以供开发。 CSOF 在生产用于早期体外和体内测试的优化化合物方面也发挥着重要作用。